


Healthcare Industry NewsFeed
HSMN NewsFeed - 27 Feb 2014
Integra LifeSciences Receives FDA Clearance for Integra(R) Titanium Bone Wedges
Integra LifeSciences Receives FDA Clearance for Integra(R) Titanium Bone Wedges
HSMN NewsFeed - 27 Feb 2014
Oculus Innovative Sciences Announces Appointment of Russell Harrison to Board of Directors
Oculus Innovative Sciences Announces Appointment of Russell Harrison to Board of Directors
HSMN NewsFeed - 27 Feb 2014
Cardica Receives 510(k) Clearance For Both MicroCutter XCHANGE(TM) 30 White Cartridge And New Material
Cardica Receives 510(k) Clearance For Both MicroCutter XCHANGE(TM) 30 White Cartridge And New Material
HSMN NewsFeed - 26 Feb 2014
SafeOp Surgical Receives FDA Clearance for EPAD(TM) Neuromonitoring Device
SafeOp Surgical Receives FDA Clearance for EPAD(TM) Neuromonitoring Device
HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
HSMN NewsFeed - 24 Feb 2014
InVivo Therapeutics Names Thomas R. Ulich, MD as Its New Chief Scientific Officer
InVivo Therapeutics Names Thomas R. Ulich, MD as Its New Chief Scientific Officer
HSMN NewsFeed - 21 Feb 2014
Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension
Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension
HSMN NewsFeed - 21 Feb 2014
GC Aesthetics raises $60M to Fund Global Growth and New Product Development
GC Aesthetics raises $60M to Fund Global Growth and New Product Development
HSMN NewsFeed - 20 Feb 2014
Medtronic Announces First U.S. Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker
Medtronic Announces First U.S. Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker
HSMN NewsFeed - 20 Feb 2014
Gore REVISE Clinical Study Demonstrates Superiority of GORE VIABAHN Endoprosthesis
Gore REVISE Clinical Study Demonstrates Superiority of GORE VIABAHN Endoprosthesis
HSMN NewsFeed - 20 Feb 2014
Cyberonics Announces CE Mark Approval Of The AspireSR(TM) Generator For VNS Therapy(R)
Cyberonics Announces CE Mark Approval Of The AspireSR(TM) Generator For VNS Therapy(R)
HSMN NewsFeed - 20 Feb 2014
Nexstim Announces Publication of a Landmark Study Showing Preoperative NBS Mapping Improves Patient Outcome
Nexstim Announces Publication of a Landmark Study Showing Preoperative NBS Mapping Improves Patient Outcome
HSMN NewsFeed - 19 Feb 2014
Lilly Announces Ramucirumab Phase III Lung Cancer Trial Meets Primary Endpoint of Overall Survival
Lilly Announces Ramucirumab Phase III Lung Cancer Trial Meets Primary Endpoint of Overall Survival
HSMN NewsFeed - 19 Feb 2014
Smith & Nephew introduces the POLARSTEM(TM) cementless hip stem to the US market
Smith & Nephew introduces the POLARSTEM(TM) cementless hip stem to the US market
HSMN NewsFeed - 18 Feb 2014
Rosetta Genomics Appoints Kevin Watson as Director, Reimbursement-Managed Care
Rosetta Genomics Appoints Kevin Watson as Director, Reimbursement-Managed Care
HSMN NewsFeed - 18 Feb 2014
Iroko Pharmaceuticals Makes Strategic Additions to the Company’s Board of Directors
Iroko Pharmaceuticals Makes Strategic Additions to the Company’s Board of Directors
HSMN NewsFeed - 18 Feb 2014
Claret Medical Announces IDE Approval for U.S. Pivotal Trial of the Sentinel(TM) Cerebral Protection System
Claret Medical Announces IDE Approval for U.S. Pivotal Trial of the Sentinel(TM) Cerebral Protection System
HSMN NewsFeed - 18 Feb 2014
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
HSMN NewsFeed - 18 Feb 2014
New Smart Tool Approved by Health Canada for Enhancing Hip Replacement Surgery
New Smart Tool Approved by Health Canada for Enhancing Hip Replacement Surgery
HSMN NewsFeed - 17 Feb 2014
Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
Published Study Validates Agendia’s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
HSMN NewsFeed - 17 Feb 2014
Neurovive Pharmaceutical: NeuroVive Treats Final Patient in European Phase III Trial on CicloMulsion(R)
Neurovive Pharmaceutical: NeuroVive Treats Final Patient in European Phase III Trial on CicloMulsion(R)
